Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 97

1.

A controlled clinical trial with a specifically configured RNA drug, poly(I).poly(C12U), in chronic fatigue syndrome.

Strayer DR, Carter WA, Brodsky I, Cheney P, Peterson D, Salvato P, Thompson C, Loveless M, Shapiro DE, Elsasser W, et al.

Clin Infect Dis. 1994 Jan;18 Suppl 1:S88-95.

PMID:
8148460
2.

Changes in the 2-5A synthetase/RNase L antiviral pathway in a controlled clinical trial with poly(I)-poly(C12U) in chronic fatigue syndrome.

Suhadolnik RJ, Reichenbach NL, Hitzges P, Adelson ME, Peterson DL, Cheney P, Salvato P, Thompson C, Loveless M, Müller WE, et al.

In Vivo. 1994 Jul-Aug;8(4):599-604.

PMID:
7893988
3.

Mismatched double-stranded RNA: polyI:polyC12U.

[No authors listed]

Drugs R D. 2004;5(5):297-304.

PMID:
15357629
4.

A double-blind, placebo-controlled, randomized, clinical trial of the TLR-3 agonist rintatolimod in severe cases of chronic fatigue syndrome.

Strayer DR, Carter WA, Stouch BC, Stevens SR, Bateman L, Cimoch PJ, Lapp CW, Peterson DL; Chronic Fatigue Syndrome AMP-516 Study Group, Mitchell WM.

PLoS One. 2012;7(3):e31334. doi: 10.1371/journal.pone.0031334. Epub 2012 Mar 14.

5.

Upregulation of the 2-5A synthetase/RNase L antiviral pathway associated with chronic fatigue syndrome.

Suhadolnik RJ, Reichenbach NL, Hitzges P, Sobol RW, Peterson DL, Henry B, Ablashi DV, Müller WE, Schröder HC, Carter WA, et al.

Clin Infect Dis. 1994 Jan;18 Suppl 1:S96-104.

PMID:
8148461
6.

Synergistic inhibition of AZT-resistant HIV by AZT combined with poly(I):poly(C12U), without synergistic toxicity to bone marrow progenitor cell elements.

Gillespie D, Hubbell HR, Carter WA, Midgette P, Elsasser W, Mullaney R, Strayer DR.

In Vivo. 1994 May-Jun;8(3):375-81.

PMID:
7803722
7.

Biologic effects after a single dose of poly(I):poly(C12U) in healthy volunteers.

Hendrix CW, Margolick JB, Petty BG, Markham RB, Nerhood L, Farzadegan H, Ts'o PO, Lietman PS.

Antimicrob Agents Chemother. 1993 Mar;37(3):429-35.

8.

Results of a double-blind placebo-controlled study of the double-stranded RNA drug polyI:polyC12U in the treatment of HIV infection.

Thompson KA, Strayer DR, Salvato PD, Thompson CE, Klimas N, Molavi A, Hamill AK, Zheng Z, Ventura D, Carter WA.

Eur J Clin Microbiol Infect Dis. 1996 Jul;15(7):580-7.

PMID:
8874076
9.

RNA drug therapy acting via the 2-5A synthetase/RNase L pathway.

Suhadolnik RJ, Reichenbach NL, Hitzges PM, Ablashi DV, Strayer DR, Carter WA.

Ann N Y Acad Sci. 1993 Jun 23;685:756-7. No abstract available.

PMID:
8363281
10.
11.

Fatigue that doesn't go away.

Propsner NM.

N J Med. 1999 Jun;96(6):29-31.

PMID:
10384764
12.
13.

Intravenous immunoglobulin is ineffective in the treatment of patients with chronic fatigue syndrome.

Vollmer-Conna U, Hickie I, Hadzi-Pavlovic D, Tymms K, Wakefield D, Dwyer J, Lloyd A.

Am J Med. 1997 Jul;103(1):38-43.

PMID:
9236484
14.

Randomised controlled trial of graded exercise in chronic fatigue syndrome.

Wallman KE, Morton AR, Goodman C, Grove R, Guilfoyle AM.

Med J Aust. 2004 May 3;180(9):444-8.

PMID:
15115421
15.

Cognitive behavioural therapy in chronic fatigue syndrome: a randomised controlled trial of an outpatient group programme.

O'Dowd H, Gladwell P, Rogers CA, Hollinghurst S, Gregory A.

Health Technol Assess. 2006 Oct;10(37):iii-iv, ix-x, 1-121.

16.

Immunologic and psychologic therapy for patients with chronic fatigue syndrome: a double-blind, placebo-controlled trial.

Lloyd AR, Hickie I, Brockman A, Hickie C, Wilson A, Dwyer J, Wakefield D.

Am J Med. 1993 Feb;94(2):197-203.

PMID:
8430715
17.

A placebo-controlled, double-blind, randomized controlled trial of a natural killer cell stimulant (BioBran MGN-3) in chronic fatigue syndrome.

McDermott C, Richards SC, Thomas PW, Montgomery J, Lewith G.

QJM. 2006 Jul;99(7):461-8. Epub 2006 Jun 29.

18.

Cognitive functioning in chronic fatigue syndrome and the role of depression, anxiety, and fatigue.

Short K, McCabe M, Tooley G.

J Psychosom Res. 2002 Jun;52(6):475-83.

PMID:
12069872
19.

Treatment with staphylococcus toxoid in fibromyalgia/chronic fatigue syndrome--a randomised controlled trial.

Zachrisson O, Regland B, Jahreskog M, Jonsson M, Kron M, Gottfries CG.

Eur J Pain. 2002;6(6):455-66.

PMID:
12413434
20.

[Cognitive function and psychological characteristics of patients with chronic fatigue syndrome].

Li YJ, Gao XG, Wang DX, Lin T, Bai XL, Yang FZ.

Zhonghua Yi Xue Za Zhi. 2005 Nov 2;85(41):2926-9. Chinese.

PMID:
16324367
Items per page

Supplemental Content

Write to the Help Desk